Involvement of Endothelial CD44 during in Vivo Angiogenesis

This publication has 50 references indexed in Scilit:

• Laminin α5 Chain Metastasis- and Angiogenesis-Inhibiting Peptide Blocks Fibroblast Growth Factor 2 Activity by Binding to the Heparan Sulfate Chains of CD44
  Cancer Research, 2005
• The over-expression of HAS2, Hyal-2 and CD44 is implicated in the invasiveness of breast cancer
  Experimental Cell Research, 2005
• HYAL1 Hyaluronidase: A Molecular Determinant of Bladder Tumor Growth and Invasion
  Cancer Research, 2005
• Human neutrophils promote angiogenesis by a paracrine feedforward mechanism involving endothelial interleukin-8
  American Journal of Physiology-Heart and Circulatory Physiology, 2005
• Engagement of CD44 modulates cyclooxygenase induction, VEGF generation, and cell proliferation in human vascular endothelial cells
  The FASEB Journal, 2004
• Recombinant CD44-HABD is a novel and potent direct angiogenesis inhibitor enforcing endothelial cell-specific growth inhibition independently of hyaluronic acid binding
  Oncogene, 2004
• Regulation of neovascularization by human neutrophil peptides (α‐defensins): a link between inflammation and angiogenesis
  The FASEB Journal, 2004
• PECAM-1 (CD31) Expression Modulates Bleeding Time in Vivo
  The American Journal of Pathology, 2000
• The PHSRN sequence induces extracellular matrix invasion and accelerates wound healing in obese diabetic mice
  Journal of Clinical Investigation, 2000
• Hyaluronate receptors: key players in growth, differentiation, migration and tumor progression
  Current Opinion in Cell Biology, 1994